Just as with most active proteins in BC dormancy, the exact role of PARP in the survival of dormant BC cells remains unknown, although its inhibition appears to hold therapeutic potential in eliminating dormant BC cells, which in turn reduces metastatic recurrence. This evidence concerns the gene PARP1 and breast cancer.